SARS-CoV-2 targets ribosomal RNA biogenesis

Area of Science:

• Molecular Biology
• Virology
• Cell Biology

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection impairs host gene expression, aiding viral replication.
• The SARS-CoV-2 virulence factor, non-structural protein 1 (Nsp1), is known to inhibit host translation by binding to mature ribosomes.

Purpose of the Study:

• To investigate the mechanisms by which SARS-CoV-2 Nsp1 affects host protein synthesis.
• To determine if Nsp1 impacts ribosome biogenesis in addition to mature ribosome function.

Main Methods:

• Analysis of ribosomal RNA (rRNA) processing during SARS-CoV-2 infection.
• Expression of SARS-CoV-2 Nsp1 in host cells to observe its effects.
• Localization studies of Nsp1 within the cell nucleus and nucleolus.
• Investigation of Nsp1 interactions with precursor rRNA.

Main Results:

• SARS-CoV-2 infection and Nsp1 expression disrupt the processing of 18S and 28S ribosomal RNAs (rRNAs).
• Nsp1 localizes to the nucleolus and directly interferes with precursor-rRNA maturation.
• Nsp1 hinders rRNA production independently of its effect on mature ribosomes.

Conclusions:

• SARS-CoV-2 Nsp1 employs a dual strategy to limit host protein synthesis: inhibiting ribosome biogenesis and targeting mature ribosomes.
• Understanding Nsp1's comprehensive impact on translation, from ribosome production to function, is crucial for developing antiviral strategies.